Helsinn Therapeutics (U.S.), Inc.
A Senior Financial Analyst at a pharmaceutical company focuses on revenue forecasting, market access finance, and business development financial modeling. The role involves leading financial modeling across budget, forecast, and long-range planning processes, supporting business development initiatives through valuation modeling, and providing financial insights to senior leadership.
Headquarters
Pazzallo, Ticino, Switzerland
Company Size
201-500 employees
Founded
1976
Helsinn is a Swiss pharmaceutical group, founded in 1976 and headquartered in Lugano, that discovers, develops, manufactures and commercializes oncology and supportive-care medicines. The company focuses on cancer supportive care, rare and niche therapies and oncology agents, offering integrated services across clinical development, regulatory affairs, quality manufacturing and commercialization both for its own brands and as a partner to other biopharma companies. Helsinn operates globally through subsidiaries and partners across Europe, the Americas and Asia, with a strong emphasis on patient-centric innovation, access to treatment and high-quality, compliant production. It also pursues research collaborations and real-world evidence to support therapeutic value and sustainable, ethical business practices.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Helsinn Therapeutics (U.S.), Inc..
95% above the average for this role